| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | +0.0% |
| R&D Expense | $8.7M | +7.4% |
| SG&A Expense | $5.5M | -4.0% |
| Operating Income | -$14.6M | -43.2% |
| Pre-tax Income | -$14.1M | -38.8% |
| Income Tax | $3K | +9.9% |
| Net Income | -$14.1M | -38.8% |
| EPS (Basic) | -$0.29 | -38.1% |
| EPS (Diluted) | -$0.29 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.5M | -74.1% |
| Short-term Investments | $40.0M | — |
| Current Assets | $59.0M | -18.1% |
| Total Assets | $74.2M | -15.2% |
| Current Liabilities | $3.2M | +12.5% |
| Total Liabilities | $3.9M | +4.9% |
| Stockholders' Equity | $70.2M | -16.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.9M | -37.6% |
| Capital Expenditures | $5K | -82.6% |
| Investing Cash Flow | -$40.0M | — |
| Financing Cash Flow | $8K | -100.0% |
| Free Cash Flow | -$12.9M | -37.3% |
| -38.1% |